Advance Local

A Framingham biotech just became a $1.9B Italian acquisition. Here’s the drug behind it

A Massachusetts pharma company just got absorbed by a European giant — and the drug at the center of it all treats a deadly disease.

Read the original at Advance Local

More audio from Advance Local